ClinicalTrials.gg
RecruitingNCT06145516PROSAP-AUpdated May 6, 2026

Promoting Sleep to Alleviate Pain - Arthroplasty

An interventional study of Cognitive behavioral therapy for insomnia (CBT-I) and Sleep education therapy (SET) in Osteoarthritis, Knee, Osteoarthritis, Hip and Insomnia, sponsored by Uppsala University. Recruiting at 1 site in Sweden. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-05-06.

Sponsored by Uppsala University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 54 studies in Osteoarthritis, Knee with a site in Sweden — 12 open to participants now, 19 under way, none of them phase 3. Osteoarthritis, Knee · Sweden.

Planned enrollment
27th of 38
100 · median 175
Started
2025
with 3 others
No phase
23 of 54
7 open now
Primary completion
2029-12
later than 15 of 18 live
Registered
41st of 54
by date

Among the 54 studies in Osteoarthritis, Knee with a site in Sweden, this one is the 27th largest by planned enrollment of the 38 interventional ones that give a count, is one of 4 that started in 2025, is one of 23 with no phase, reaches primary completion later than 15 of the 18 other live ones, and was the 41st registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

12 of the 54 studies in Osteoarthritis, Knee with a site in Sweden are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 18 Years to 100 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 54 studies in Osteoarthritis, Knee with a site in Sweden, or all of them as a file.
02

Study summary

PROSAP-A is a perioperative randomized, controlled trial with a 12-month follow-up period after total knee arthroplasty (TKA) or total hip arthroplasty (THA), aiming to investigate both acute and long-term postoperative effects of preoperative sleep-promotion. Participants with clinically significant insomnia symptoms will be randomized to a brief, hybrid version of cognitive behavioral therapy for insomnia (CBT-I) or sleep education therapy, administered over a 4-week period, prior to surgery. The primary objective is to evaluate effects of preoperative sleep-promotion on acute postoperative pain control. Secondary objectives include evaluation of postoperative sleep, recovery, mental health, cognitive function and alterations in blood biomarkers.

Read the detailed description

Although preoperative sleep disturbance is associated with poorer acute postoperative pain control, as well as development of chronic postsurgical pain, only very limited attempts have been made to target preoperative sleep to achieve improved postoperative outcomes. This study addresses two chronic pain populations, TKA and THA patients, that suffer severely due to both sleep disturbance and painful symptoms. Patients who meet eligibility criteria, including insomnia severity index score >10 and confirmed DSM-V criteria for persistent insomnia disorder, will be randomized to a brief, hybrid version of CBT-I or sleep education therapy over a 4-week period, before surgery. The CBT-I will focus on the two components which have shown the highest efficacy for sleep improvement, sleep restriction therapy and stimulus control. The CBT-I treatment will be administered in self-guided digital format with addition of telehealth video-consultations with a psychologist one time per week. The sleep education therapy will also be provided in a hybrid format, including digital sessions and video-consultations with a research nurse. There will also be a booster session 1-2 weeks postoperative for both interventions. Participants will be carefully evaluated during on-site visits two times preoperative, pre- and post-intervention, and one time 6 months postoperative. During on-site visits, participants will complete multiple questionnaires (covering pain, pain catastrophizing, mental health, physical function, activity etc), undergo digital cognitive testing, quantitative sensory testing (QST, to determine pain detection thresholds to different stimuli, assess temporal summation, pain inhibitory capacity), provide blood samples, and initiate actigraphy (objective assessment of sleep continuity measures). In addition to the on-site visits, participants will complete questionnaires remotely 3 and 12 months after surgery.

03

Conditions studied

  • Osteoarthritis, Knee
  • Osteoarthritis, Hip
  • Insomnia
  • Surgery
  • Pain, Postoperative
  • Postoperative Complications

Keywords

  • osteoarthritis
  • total knee arthroplasty
  • total hip arthroplasty
  • insomnia
  • sleep disturbance
  • postoperative pain
04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age ≥18 years
  • insomnia severity index score >10
  • fulfill criteria for persistent insomnia disorder
  • average pain numerical rating scale (NRS) score ≥4 (scale 0 - 10) and/or movement-related pain NRS score ≥4 after 5 minutes walking
  • scheduled to undergo primary (first-time, i.e., not revision surgery) TKA or THA due to osteoarthritis

Exclusion criteria

Exclusion Criteria:

  • uncontrolled medical disorders
  • nightshift work
  • ongoing major depressive disorder, bipolar disorder, psychotic disorder, substance dependence
  • current history or high likelihood of primary sleep disorders (other than insomnia), including obstructive sleep apnea syndrome, narcolepsy, nocturnal myoclonus
  • severely impaired vision (precluding ability to take part of study interventions)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Cognitive behavioral therapy for insomnia (CBT-I)

    The CBT-I treatment will be administered in self-guided digital format over 4 weeks with addition of telehealth video-consultations with a psychologist one time per week. The CBT-I will focus on sleep restriction therapy and stimulus control, which have shown the highest efficacy for sleep improvement among components typically incorporated. A booster session will be provided 1-2 weeks postoperative.

    Behavioral: Cognitive behavioral therapy for insomnia (CBT-I)

  • Active comparator
    Sleep education therapy (SET)

    The sleep education therapy will be administered in self-guided digital format over 4 weeks with addition of telehealth video-consultations with a research nurse one time per week. The SET will focus on sleep physiology, different sleep disturbances and sleep hygiene measures. A booster session will be provided 1-2 weeks postoperative.

    Behavioral: Sleep education therapy (SET)

Interventions

  • BehavioralCognitive behavioral therapy for insomnia (CBT-I)

    Hybrid CBT-I (self-guided digital format focusing on sleep restriction therapy and stimulus control + telehealth video-consultations with psychologist)

  • BehavioralSleep education therapy (SET)

    Self-guided digital sleep education (sleep hygiene, sleep physiology, sleep disturbances etc) + telehealth video-consultations with research nurse

06

What researchers measure

Primary outcomes

  1. Acute postoperative pain intensity

    Average pain intensity (NRS 0 - 10) over the past 24 h rated each morning, averaged over 7 days

    Time frame: First 7 postoperative days

Secondary outcomes

  1. Pre- and acute postoperative change in sleep measures from baseline

    insomnia severity index, Pittsburgh sleep quality index, actigraphic sleep continuity measures (sleep onset latency, total sleep time, wakefulness after sleep onset, sleep efficiency)

    Time frame: Up to 2 weeks postoperative

  2. Acute postoperative opioid consumption

    Oral morphine mg equivalents (OMEQs)

    Time frame: Postoperative day (POD) 1 and POD1-7

  3. Recovery in the acute postoperative phase

    Quality of recovery (QoR) 15 score

    Time frame: First 7 postoperative days

  4. Long-term postoperative sleep quality

    insomnia severity index

    Time frame: Up to 12 months postoperative

  5. Postoperative objective sleep continuity

    actigraphic sleep efficiency \[SE\]

    Time frame: Up to 6 months postoperative

  6. Pain intensity 6 months postoperative

    Average pain intensity (NRS 0 - 10) over the past 24 h rated each morning, averaged over 7 days

    Time frame: 6 months postoperative

  7. Change in pain measures from baseline

    BPI pain severity and pain interference score, QoR-15 pain score, WOMAC OA pain score

    Time frame: Up to 12 months postoperative

  8. Changes in quantitative sensory testing (QST) measures of pain

    Pressure pain threshold, temporal summation, conditioned pain modulation, cold pressor test

    Time frame: Up to 6 months postoperative

  9. Change in cognitive function

    Digital cognitive testing (Mindmore platform) incl. memory, attention and processing speed, executive functions

    Time frame: Up to 6 months postoperative

  10. Change in anxiety from baseline

    Generalized anxiety disorder 7 (GAD-7) score

    Time frame: Up to 6 months postoperative

  11. Change in depression from baseline

    Patient health questionnaire 9 (PHQ-9) score

    Time frame: Up to 6 months postoperative

  12. Change in quality of life

    EuroQol 5 dimension 5 level (EQ-5D-5L), RAND-36

    Time frame: Up to 6 months postoperative

  13. Change in health-related function

    EQ-5D-5L, RAND-36

    Time frame: Up to 6 months postoperative

  14. Change in osteoarthritis-related symptoms

    WOMAC OA

    Time frame: Up to 12 months postoperative

Other outcomes

  1. Change in physical activity

    International physical activity questionnaire short form (IPAQ-sf)

    Time frame: Up to 6 months postoperative

  2. Change in pain catastrophizing

    Pain catastrophizing scale (PCS)

    Time frame: Up to 6 months postoperative

  3. Change in kinesiophobia

    Tampa scale of kinesiophobia (TSK)

    Time frame: Up to 6 months postoperative

  4. Change in subjective pain sensitivity

    Pain sensitivity questionnaire (PSQ)

    Time frame: Up to 6 months postoperative

  5. Fibromyalgia severity score

    Sum of widespread pain index + symptom severity scale (ACR 2016)

    Time frame: Up to 6 months postoperative

  6. Pain-related acceptance

    Chronic pain acceptance questionnaire (CPAQ-8)

    Time frame: Up to 6 months postoperative

  7. Changes in blood biomarkers

    Inflammatory mediators, monoamine metabolites, coagulation system etc

    Time frame: Up to 6 months postoperative

07

Study locations

1 of 1 sites recruiting
  • Department of Surgical Sciences, Uppsala University
    Uppsala, Uppland 75185, Sweden
    Recruiting
    • Andrea Niklasson, M.D. · Contactandrea.niklasson@gmail.com · 0046186122110
    • Martin F Bjurström, Associate Professor · Principal investigator
08

References and documents

Publications

  • Bjurstrom MF, Bothelius K, Maathz P, Jernelov S, Kraepelien M, Rosenstrom AHC, Niklasson A, Smith MT, Olmstead R, Irwin MR, Finan PH, Kosek E. Randomised, controlled clinical trial evaluating the effects of preoperative insomnia treatment on postoperative pain control and recovery: a protocol for the Promoting Sleep to Alleviate Pain-Arthroplasty (PROSAP-A) trial. BMJ Open. 2025 Jul 30;15(7):e099785. doi: 10.1136/bmjopen-2025-099785. PubMed 40738630 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Dec 2029, 51 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 51 months is above that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 17, 2023
First posted
Nov 24, 2023
StartActual
Sep 1, 2025
Primary completionEst.
Dec 1, 2029
CompletionEst.
Dec 1, 2030
Last update
May 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06145516
Lead sponsor
Uppsala University
Responsible party
Sponsor
First posted
Nov 24, 2023
Start date
Sep 1, 2025
Primary completion
Dec 1, 2029 (estimated)
Completion
Dec 1, 2030 (estimated)
Last update
May 6, 2026

Study contacts

Martin F Bjurström, MD, PhD
Contact
martin.flores.bjurstrom@uu.se
+46739512728
Martin F Bjurström, MD, PhD
principal investigator · Uppsala University / Uppsala University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion